Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Deafness unilateral, Gait disturbance, Nausea, Vision blurred
Clinical narrative: balance issues/unbalanced; blurred vision; nausea; loss of hearing in one ear/deafness in one ear; difficulty walking/could not walk across the room; This spontaneous case was reported by a patient and describes the occurrence of NAUSEA (nausea), DEAFNESS UNILATERAL (loss of hearing in one ear/deafness in one ear), GAIT DISTURBANCE (difficulty walking/could not walk across the room), BALANCE DISORDER (balance issues/unbalanced) and VISION BLURRED (blurred vision) in a female patient of an unknown age who received mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (batch no. ASKU) for COVID-19 prophylaxis.     No Medical History information was reported.    On 20-Sep-2024, the patient received dose of mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (unknown route) 1 dosage form. On 21-Sep-2024, the patient experienced NAUSEA (nausea) (seriousness criteria hospitalization and disability), DEAFNESS UNILATERAL (loss of hearing in one ear/deafness in one ear) (seriousness criteria hospitalization, disability and medically significant) and GAIT DISTURBANCE (difficulty walking/could not walk across the room) (seriousness criteria hospitalization and disability). On an unknown date, the patient experienced BALANCE DISORDER (balance issues/unbalanced) (seriousness criteria hospitalization and disability) and VISION BLURRED (blurred vision) (seriousness criteria hospitalization and disability). The patient was hospitalized from 23-Sep-2024 to sometime in September 2024 due to BALANCE DISORDER, DEAFNESS UNILATERAL, GAIT DISTURBANCE, NAUSEA and VISION BLURRED. At the time of the report, NAUSEA (nausea) and GAIT DISTURBANCE (difficulty walking/could not walk across the room) was resolving and DEAFNESS UNILATERAL (loss of hearing in one ear/deafness in one ear), BALANCE DISORDER (balance issues/unbalanced) and VISION BLURRED (blurred vision) had not resolved.        For mRNA-1273.712 (SPIKEVAX 2024-2025 PFS) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medication were reported.  Patient did not receive any other vaccines in the 4 weeks prior to COVID-19 vaccine. Patient had experienced a serious reaction to the latest COVID-19 vaccine booster shot, which she received on September 20, 2024. The following day, she experienced nausea, loss of hearing in one ear, and difficulty walking. She was admitted to the emergency room on September 23 and spent a week in the hospital, followed by two weeks in rehabilitation. She continued to face challenges, including deafness in one ear, blurred vision, and balance issues. Patient expressed her frustration regarding the promotion of the vaccine, stating that she felt it was unacceptable to experience such severe health complications after receiving the shot.  Patient thought that it was terrible that advertised to take this shot and then patient subjected to this illness.   Most recent FOLLOW-UP information incorporated above includes: On 22-Oct-2024: Live follow up received which contains non-significant information, narrative and reference number were added.; Reporter's Comments: The benefit-risk relationship of the product is not affected by this report.